THE CELIAC PATIENT - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

THE CELIAC PATIENT

Description:

Screening anti-tTG IgA antibody positive. Occasional indigestion with pasta meals ... Irritable Bowel Syndrome Primary Biliary Cirrhosis Turner's and Down's Syndrome ... – PowerPoint PPT presentation

Number of Views:347
Avg rating:3.0/5.0
Slides: 35
Provided by: banaj
Category:

less

Transcript and Presenter's Notes

Title: THE CELIAC PATIENT


1
THE CELIAC PATIENT
  • Carol E. Semrad, M.D.
  • Associate Professor of Medicine
  • The University of Chicago

2
  • Celiac Disease
  • Sprue
  • Gluten-enteropathy
  • Celiac sprue
  • Inflammatory disease of the small bowel with a
    known trigger

Same Disease
3
A Case of Asymptomatic Celiac Disease
  • 50 y.o. woman, Italian/Irish
  • Daughter diagnosed with celiac disease
  • Screening anti-tTG IgA antibody positive
  • Occasional indigestion with pasta meals
  • PMH Hypothyroidism
  • FH Parents of short stature
  • Physical examination obese, height 51

4
Duodenum
5
  • Further Studies - Mild
    anemia, transaminitis, iron deficient
    - BMD osteopenia
  • Diagnosis - Celiac
    disease
  • Management
    - Gluten-free diet
    - Iron
    therapy - Further
    evaluation of bone disease - Monitor for
    improvement

6
Celiac Disease -Trigger
7
Gluten (the protein component of wheat)
Glutenins (alcohol-insoluble fraction)
Gliadin (toxic alcohol-soluble fraction)
Peptides (33-mer not degraded by human
peptidases, contains toxic epitopes)
Amino acids (non-toxic to celiac patients)
8
Celiac Disease GENES
  • 95 HLA DQ2 heterodimer alleles DQA10501 and
    DQB10201 (20-30 normals carry these alleles)
  • 5 HLA DQ8 heterodimer alleles DQA10301 and
    DQB10302
  • Rarely DQ2 half-heterodimer
  • Non-HLA genes not yet identified

9
ADAPTIVE
INNATE
Intraepithelial CTL NK-like cells
?
Lamina Propria
Modified from Green and Jabri Lancet.
2003362383-91.
10
Celiac Disease Prevalence in the U.S.A.
  • Based on GI symptoms 14500
  • Based on Antibody studies 1250 (performed in
    blood donors)
  • 1 of the Caucasian population

11
Classical Celiac Disease (14500)
Atypical Silent Latent
Detected by screening (1250)
12
The clinical presentation of celiac disease is
changing
Rampertab SD et al., Am J Medicine 2006
13
Celiac Disease Clinical Presentation
  • Classical
  • Diarrhea
  • Gas/bloating
  • Weight loss
  • Atypical
  • Constipation
  • Dyspepsia
  • Anemia
  • Osteoporosis
  • Rash
  • Neuropathy/ataxia
  • Hepatitis
  • Dental enamel hypoplasia
  • Infertility
  • Silent
  • No sxs/signs
  • Positive Ab
  • Abnormal bx
  • Latent
  • No sxs/signs
  • Positive Ab
  • Normal bx
  • OR
  • CD in remission

14
Celiac Disease
Classic, Atypical, Silent
Latent
Normal
Abnormal
15
(No Transcript)
16
Celiac Disease Diagnostic Tools
Duodenal biopsy Serologies HLA
Association anti-tTG IgA, IgG DQ2 A105
B102 anti-EMA IgA DQ8 A103
B10302 (anti-DGP) Half DQ2 heterodimer
17
Antibodies Associated with Celiac Disease IgA
Antibody Sensitivity Specificity Method
Anti-gliadin 57-100 42-98 ELISA
Anti-endomysial 75-98 96-100 Indirect IF
Anti-tissue transglutaminase 98-100
97-98 ELISA False Negative with IgA
deficiency False Positive tTG in IBD,
PBC Positive Predictive Value 100 for
EMA 80 for human tTG
Fasano, Catassi. Gastro2001120636
Carroccio et al. Clin Chem 2002481546
18
CELIAC DISEASE

ENDOSCOPY
Normal
Scalloped
Gluten-free diet
HISTOLOGY
Increased IEL
Villous atrophy
Recovering
19
Celiac DiseaseWho Should Undergo Duodenal Biopsy?
  • High risk with GI symptoms
  • Dermatitis Herpetiformis
  • Unexplained iron deficiency anemia
  • Early osteoporosis/bone fracture
  • Neuropathy/ataxia
  • Positive screening antibody test

20
Celiac DiseaseWho Should Have Antibody Testing?
  • Support diagnosis
  • Screening High risk groups First and second
    degree relatives Dermatitits Herpeteformis Typ
    e I Diabetes Mellitus Autoimmune thyroid
    disease Irritable Bowel Syndrome Primary
    Biliary Cirrhosis Turners and Downs Syndrome

21
Celiac diseaseAn approach to antibody screening
  • tTG IgA antibody and serum IgA level
  • If positive, confirm with EMA antibody

22
Celiac DiseaseWhen is HLA Genotyping Helpful?
  • Family Members -Negative predictive value
  • Difficulty in securing a diagnosis
  • - Self-started a gluten-free diet
  • - Equivocal small bowel biopsy findings
  • - Positive antibody with normal biopsy
  • - IgA deficiency

23
Celiac Disease Evaluation
  • Bone mineral density study - abnormal bone
    mass in 60 - men women - if abnormal
    obtain 25-OH Vit D, PTH, calcium, 24 hour
    urine calcium
  • Vitamin/mineral levels in those with evidence of
    malabsorption/diarrhea - Iron studies and
    folate - Vitamin A, B12, zinc

24
Celiac Disease Treatment
  • Life-long strict gluten-free diet -
    knowledgeable nutritionist - celiac center web
    sites/support groups (U. Chicago, Columbia,
    Mayo Clinic, Stanford, U. Maryland, B.I.
    Boston)
  • Oats are tolerated by most
  • Daily multiple vitamin and calcium
  • Folic Acid for women of child-bearing age
  • No initial role for bisphosphonates

25
Celiac Disease Monitoring
  • Resolution of symptoms
  • tTG antibodies for dietary adherence (?
    correlation between Ab titer and histology)
  • Weight (risk for obesity)
  • Cholesterol level
  • Bone Mineral Density

26
RESPONSE TO A GLUTEN-FREE DIET 90
IMPROVE 10 FAIL TO IMPROVE (within 2
weeks) Dietary indiscretion Lactose or
fructose Intolerance Microscopic colitis
Wrong Diagnosis Pancreatic
Insufficiency Bacterial overgrowth Refract
ory sprue
27
Refractory Sprue Continued symptoms and small
bowel atrophy despite a strict gluten-free diet
  • TYPE I
  • - normal T-lymphocytes population
  • - often responds to steroids, good prognosis
  • TYPE II
  • -abnormal T cell population (CD3, CD8-)
    T-cell receptor- g gene rearrangements
    - often requires parenteral nutrition
  • - progression to lymphoma
  • - poor prognosis
  • - trials with cytotoxic chemo or stem cell
    transplant

28
Celiac Disease Long Term Complications
  • Anemia
  • Osteoporosis
  • Intestinal T-cell lymphoma ? Video capsule
    endoscopy screening
  • Other Malignancies Gastrointestinal Meleno
    ma Non-Hodgkins Lymphoma

29
Celiac Disease Future Treatments
  • Bacterial Prolyl Endopeptidase
  • Genetically altered wheat grain
  • Specific Inhibitors HLA DQ2 tTG
    IL15
  • Tight junction modulators

30
Summary CELIAC DISEASE
  • T-cell mediated small bowel mucosa inflammation
  • Triggered by gluten in the diet in those
    genetically predisposed
  • Malabsorption of nutrients
  • Presents age 2 yrs, young adults, or any age
  • Diagnosis made by abnormal small bowel biopsy
    that reverts to normal on a gluten-free diet
  • Treatment is a life-long strict GF-diet

31
How Much Gluten Is Toxic?
32
CELIAC DISEASE
Dose-dependent Effect of Gliadin on Small Bowel
capsule of gluten
Catassi et al. GUT 1993 34 1515 Ciclitira et
al. Clin Sci 1984 66 357 Catassi et al.
Gastroenterol 2005128A253
33
10 mg gliadin 250 mg wheat flour(less than an
1/8 teaspoon flour)
34
CELIAC DISEASE
Are Dietary Oats Tolerated?
Janatuinen et al. NEJM 19953331033 Gut 2002
50 332 Hogberg et al. Gut 200453649
Write a Comment
User Comments (0)
About PowerShow.com